Direxion Daily HOOD Bull 2X ETF (HODU)
Live price chart, market sentiment, and community perspectives for Direxion Daily HOOD Bull 2X ETF (NASDAQ: HODU).
Live price chart, market sentiment, and community perspectives for Direxion Daily HOOD Bull 2X ETF (NASDAQ: HODU).
On our desk, the divide on HODU is stark. While high-profile voices like Tom Lee suggest avoiding the underlying stock for 2026, other fund managers remain deeply committed to Vlad Tenev and Robinhood's strategic pivots. From a sentiment standpoint, you have retail and tactical desks weighing heavy macro headwinds—like sequential drops in customer assets and lagging crypto volumes—against aggressive upside engineering like sports derivatives and prediction markets during major events like the World Cup. Navigating this means accepting extreme volatility, especially when the underlying equity has shed a substantial portion of its value earlier in the year.
Watching the 50-day moving average on HODU has given our technical trading team clear guardrails. Recent chart analysis highlights a fledgling price downtrend accompanied by a bearish MACD line crossover where both lines are trending lower. Even though Deutsche Bank analyst Brian Bedell reiterated a buy rating and boosted his price target on the underlying stock to $98, the immediate technical setup for the 2X leveraged ETF warns of strong downside pressure. When evaluating entry points for short-term upside, traders must weigh these bearish momentum signals against institutional target revisions and declining short interest metrics.
Reviewing the structural architecture of HODU, our risk management group emphasizes that this vehicle is strictly a short-term trading tool rather than a buy-and-hold investment. Seeking daily investment results of 200% of Robinhood's common shares means the ETF eliminates diversification benefits and compounds daily tracking errors. With the fund sitting at a NAV around $10.34 and featuring a gross expense ratio near 0.99%, participants must account for decay over periods longer than a single trading session. It is entirely built for nimble traders who understand compounding risks, not passive capital allocators.
Explore plasma cleansing, somatic organ swaps, and BCI.